Nominations have opened for the GSK Award for Research Excellence.
The award, which is now in its 38th year, aims to assist Australian research by providing the recipient with an $80,000 grant.
The grant has been awarded since 1980 to recognise outstanding achievements in medical research with potential importance to human health.
Last year’s recipient was received by Professor Timothy Hughes – considered a world-leader in chronic myeloid leukaemia (CML) research – for pioneering the use of tyrosine kinase inhibitors (TKIs) in the treatment of CML.
According to Professor Hughes, “Awards like GSK’s Award for Research Excellence bring much needed support to the research community in Australia. Not only through the direct impact of the award’s funding, but also through raising awareness of the scientific expertise and innovative activities in our country.”
The award was presented to Professor Hughes at Research Australia’s Health and Medical Research Awards 2017. Dr Andrew Weekes, medical director of GSK Australia, Said, “GSK is proud to be able to support Australian researchers with this award, now in its 38th year."
Successful applicants are generally mid-career researchers with a long-standing commitment to their field. The winner will be announced on Thursday 8 November 2018 at the Annual Research Australia Awards in Sydney. Nominations close on 2 July 2018.